Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

CB1 Activators

CB1 activators constitute a unique class of compounds designed to interact with the cannabinoid receptor type 1 (CB1), a crucial player in the central nervous system. These molecules, with diverse structures, modulate the endocannabinoid system, a pivotal regulator of various physiological processes. CB1 activators influence intricate signaling pathways, showcasing their impact on cellular responses. This class exhibits structural diversity, ranging from endogenous cannabinoids to synthetic derivatives. Notably, some members mimic endogenous cannabinoids, while others showcase distinct chemical backbones. This structural variability underscores the adaptability of CB1 activators, allowing them to interact with CB1 receptors in unique ways. CB1 activators exert their effects by binding to CB1 receptors, initiating complex intracellular signaling events. The class encompasses compounds with diverse pharmacological implications, influencing processes such as pain modulation and synaptic plasticity. Their ability to modulate neurotransmitter release highlights the functional significance of CB1 activators in cellular communication. Some CB1 activators demonstrate neuroprotective properties, hinting at their potential in mitigating excitotoxicity. Others exhibit vasorelaxant effects, showcasing the class's impact on peripheral systems. The functional significance of CB1 activators lies in their ability to influence various physiological responses, providing a broad spectrum of applications. Understanding the molecular dynamics of CB1 activators is crucial for unraveling their biological effects. These compounds interact with CB1 receptors, influencing downstream cellular responses. The intricate balance between structural features and receptor binding dynamics within the CB1 activator class contributes to their potency and prolonged effects. In summary, CB1 activators represent a versatile class of compounds that impact diverse physiological processes through their interaction with CB1 receptors. The structural variability and pharmacological implications of this class make it a fascinating area of research, offering insights into novel pathways in neuroscience and cellular signaling. As researchers delve deeper, the promise of uncovering new pharmacological targets and mechanisms within the CB1 activator class continues to drive scientific exploration.

SEE ALSO...

Items 1 to 10 of 25 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rimonabant

168273-06-1sc-205491
sc-205491A
5 mg
10 mg
$72.00
$160.00
15
(1)

Rimonabant is a selective antagonist of the CB1 receptor, characterized by its unique ability to disrupt endocannabinoid signaling. Its molecular structure allows for specific interactions with the receptor's binding pocket, leading to conformational changes that inhibit downstream signaling pathways. This compound exhibits distinct kinetic profiles, influencing receptor desensitization and internalization, thereby modulating neurotransmitter release and synaptic plasticity in neural circuits.

Magnolol

528-43-8sc-204797
sc-204797A
5 mg
25 mg
$42.00
$185.00
1
(0)

Magnolol acts as a modulator of the CB1 receptor, showcasing a unique affinity for specific allosteric sites that influence receptor dynamics. Its molecular interactions promote subtle conformational shifts, enhancing or diminishing receptor activity. This compound exhibits intriguing reaction kinetics, affecting the rate of receptor activation and desensitization. Additionally, its hydrophobic characteristics facilitate membrane penetration, impacting cellular signaling pathways and lipid interactions.

Oleamide

301-02-0sc-358696
sc-358696A
sc-358696B
sc-358696C
sc-358696D
10 mg
25 mg
50 mg
100 mg
500 mg
$60.00
$71.00
$122.00
$214.00
$627.00
(1)

Oleamide is a fascinating compound that interacts with the CB1 receptor, exhibiting a unique ability to stabilize receptor conformations through hydrogen bonding and hydrophobic interactions. Its presence can modulate the receptor's signaling efficiency, influencing downstream pathways. The compound's lipid-like properties enhance its integration into cellular membranes, potentially altering membrane fluidity and affecting receptor localization. This interplay can lead to distinct physiological responses, showcasing its role in cellular communication.

Leelamine HCl

1446-61-3sc-200375
sc-200375A
10 mg
50 mg
$124.00
$530.00
(0)

Leelamine HCl is a notable compound that engages with the CB1 receptor, characterized by its ability to form ionic and dipole-dipole interactions, which can significantly influence receptor activation. Its unique structural features allow it to traverse lipid bilayers efficiently, impacting membrane dynamics and receptor accessibility. Additionally, Leelamine HCl may alter the kinetics of receptor-ligand binding, potentially leading to varied signaling outcomes and cellular responses.

ABN-CBD

22972-55-0sc-203488A
sc-203488B
sc-203488
sc-203488C
1 mg
5 mg
10 mg
25 mg
$36.00
$143.00
$235.00
$541.00
1
(0)

ABN-CBD is a distinctive compound that interacts with the CB1 receptor through a combination of hydrophobic and hydrogen bonding interactions, enhancing its binding affinity. Its unique conformation facilitates selective receptor engagement, potentially influencing downstream signaling pathways. The compound's ability to modulate receptor conformational states may lead to altered signal transduction dynamics, affecting cellular behavior and response patterns in complex biological systems.

Olvanil

58493-49-5sc-201454
sc-201454A
5 mg
25 mg
$47.00
$201.00
1
(0)

Olvanil exhibits a unique binding profile with the CB1 receptor, characterized by its ability to form specific hydrophobic pockets and engage in van der Waals interactions. This compound's structural flexibility allows it to adopt conformations that stabilize receptor activation, influencing allosteric modulation. Its kinetic properties suggest a rapid association and dissociation with the receptor, potentially leading to nuanced effects on intracellular signaling cascades and receptor desensitization mechanisms.

CP-55,940

83002-04-4sc-200359
sc-200359A
5 mg
25 mg
$185.00
$850.00
4
(1)

CP-55,940 demonstrates a remarkable affinity for the CB1 receptor, engaging in intricate hydrogen bonding and hydrophobic interactions that enhance its binding efficacy. Its unique stereochemistry facilitates selective receptor activation, promoting distinct signaling pathways. The compound's dynamic conformational changes contribute to its prolonged receptor engagement, influencing downstream effects on neurotransmitter release and cellular response mechanisms. This intricate interplay underscores its complex pharmacodynamics.

Arvanil

128007-31-8sc-202065
5 mg
$150.00
1
(0)

Arvanil exhibits a unique binding profile with the CB1 receptor, characterized by its ability to form specific van der Waals interactions and electrostatic contacts. This compound's structural flexibility allows it to adopt multiple conformations, optimizing its fit within the receptor's binding pocket. The kinetic properties of Arvanil facilitate rapid receptor activation, leading to nuanced modulation of intracellular signaling cascades. Its distinct molecular interactions contribute to a complex landscape of receptor dynamics and functional outcomes.

DEA

150314-35-5sc-203024
5 mg
$56.00
(0)

DEA interacts with the CB1 receptor through a combination of hydrophobic and hydrogen bonding interactions, enhancing its affinity and selectivity. Its unique steric configuration allows for effective spatial orientation within the receptor, promoting efficient signal transduction. The compound's reactivity as an acid halide enables it to participate in nucleophilic attack mechanisms, influencing downstream pathways. This dynamic interplay of molecular forces shapes its role in receptor-mediated processes.

(R)-Methanandamide

157182-49-5sc-200792
sc-200792A
5 mg
25 mg
$56.00
$175.00
1
(1)

(R)-Methanandamide exhibits a distinctive binding profile with the CB1 receptor, characterized by its ability to form multiple van der Waals interactions that stabilize the receptor-ligand complex. Its chiral nature contributes to a specific orientation that enhances receptor activation. Additionally, the compound's structural flexibility allows it to adapt to conformational changes in the receptor, facilitating a robust signaling cascade. This interplay of molecular dynamics is crucial for its functional efficacy.